*Klebsiella pneumoniae* (KP) causes a wide spectrum of infections including pneumonia, bacteraemia and skin and soft-tissue infections. The incidence of extensively drug-resistant (XDR, non-susceptible to at least one agent in all classes, but susceptible to ≤2 classes of antimicrobials) isolates have been on the rise[@ref1]. Colistin resistance is mediated by chromosomal mutations and plasmid-borne genes[@ref2]. Chromosomal mutations are predominantly reported in the genes encoding two-component systems (*mgrB, phoP, phoQ, pmrA, pmrB*) involved in lipopolysaccharide modification[@ref2]. Plasmid-mediated *mcr1-5* and its variants encoding phosphoethanolamine transferase contribute to colistin resistance.

At present, studies on molecular characterization of XDR KP (carbapenem and colistin resistant) and clonal relatedness are limited in India. This study was performed to determine the molecular resistance mechanisms and its association with clonal relationship among colistin-resistant KP. Chromosomal colistin resistance contributed by mutations in *mgrB, phoP* and *phoQ* and plasmid-mediated *mcr-1* and *mcr-3* were investigated. Multilocus sequence typing (MLST) to look for clonal types and its relationship with colistin-resistant mechanism were determined in isolates collected from various clinical specimens. Since the study isolates were carbapenem-resistant, carbapenemases were also characterized.

Material & Methods {#sec1-2}
==================

Totally 65 colistin-resistant KP isolated from clinical specimens including blood and body fluids (n=43), exudates (n=11) and respiratory specimens (n=11) collected between 2016 and 2017 at the department of Clinical Microbiology, Christian Medical College, Vellore, India, were selected retrospectively. The study protocol was approved by the Institutional Review Board. The isolates were identified up to species level as per standard procedures[@ref3]. First colistin-resistant KP isolate from a patient was included in the study.

*Phenotypic characterization:* Antimicrobial susceptibility testing was performed as per Clinical and Laboratory Standards Institute (CLSI) guidelines and interpreted based on CLSI 2016 and 2017 breakpoints[@ref4][@ref5]. The panel of antimicrobials tested included ceftazidime (30 μg), cefotaxime (30 μg), cefepime (30 μg), piperacillin/tazobactam (100/10 μg), imipenem (10 μg), meropenem (10 μg), ciprofloxacin (5 μg), gentamicin (10 μg), netilmicin (30 μg), amikacin (30 μg), minocycline (30 μg) and tigecycline (15 μg). All the isolates were carbapenem resistant which was defined as resistant to meropenem with zone diameter of ≤19 mm[@ref4][@ref5]. *Escherichia coli* ATCC 25922, *Staphylococcus aureus* ATCC 25923 and *Pseudomonas aeruginosa* ATCC 27853 were used as control strains for susceptibility testing as recommended by CLSI[@ref4][@ref5]. Susceptibility to tigecycline was interpreted with FDA breakpoints (*<http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021821s016lbl.pdf>*). Colistin minimum inhibitory concentration (MIC) was determined by reference broth-micro dilution method[@ref6][@ref7]. *mcr-1* positive *E. coli* (Courtesy: Dr Olga Perovic, National Institute for Communicable Diseases, Johannesburg, South Africa) was used as positive control and *E. coli* ATCC 25922 and *P. aeruginosa* ATCC 27853 were used as negative controls. MIC results were interpreted as per European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines 2016 and 2017, respectively[@ref6][@ref7].

Molecular characterization

[Characterization of β-lactamases:]{.ul} Bacterial DNA was extracted from 18 h cultures by Qiasymphony (Qiagen, Hilden, Germany) as per manufacturer\'s instructions. Multiplex PCR was performed for the detection of genes encoding β-lactam resistance which included EBSL (*bla*~SHV~, *bla*~TEM~, *bla*~PER~, *bla*~VEB~, *bla*~CTX-M-1~, *bla*~CTX-M-2~, *bla*~CTX-M-8~, *bla*~CTX-M-9~ and *bla*~CTX-M-25~)[@ref8][@ref9], AmpC (*bla*~ACT,~ *bla*~ACC~, *bla*~CIT~, *bla*~DHA~ and *bla*~FOX~)[@ref10] and carbapenemases (*bla*~NDM~, *bla*~VIM~, *bla*~IMP~, *bla*~OXA48-like~, *bla*~KPC~, *bla*~GES~ and *bla*~SPM~)[@ref11][@ref12][@ref13]. Known positive controls (Courtesy: International Health Management Association Inc., USA) were used.

[Characterization of colistin resistance:]{.ul} Chromosomal mutations: PCR for amplification of *mgrB, phoP* and *phoQ* genes was performed as described by Jayol *et al*[@ref14]. From the amplified product, mutations were determined by targeted sequencing. For analysis of mutations, KP ATCC 35657 was used as reference. To determine insertion sequences present in *mgrB*, the sequences were run through ISfinder (*<https://www-is.biotoul.fr/>*) and the position of insertion was assigned by aligning with reference *mgrB*. Sequencing was performed using 3500 Genetic Analyzer (Applied Biosystems, USA) as per manufacturer\'s instructions.

Sorting Intolerant From Tolerant (SIFT) scores for the non-synonymous mutations implicating in the amino acid substitutions were predicted for *mgrB, phoP* and *phoQ* genes. A value of \<0.05 for a substitution is predicted to be deleterious and affects the function of the protein (*<https://ionreporter.thermofisher.com/ionreporter/help/GUID-2097F236-C8A2-4E67-862D-0FB5875979AC.html>*). SIFT score calculates the deleterious effect based on the probability of the substituted amino acid being tolerated at a position.

Plasmid-mediated colistin resistance: To determine plasmid-borne colistin resistance, PCR was performed for *mcr-1* and *mcr-3* genes, as controls were available for these two *mcr* variants[@ref15][@ref16].

[Multilocus sequence typing (MLST):]{.ul} MLST was performed as described by Diancourt *et al*[@ref17]. Seven housekeeping genes used to determine clonal type among KP included *gapA* (coding for glyceraldehyde-3-phosphate), *infB* (coding for translation initiation factor-2), *mdh* (coding for malate dehydrogenase), *pgi* (coding for phosphoglucose isomerase), *phoE* (coding for phosphorine E), *rpoB* (coding for β-subunit of RNA polymerase B) and *tonB* (coding for periplasmic energy transducer). The sequence type was assigned by determining the allele number for each of the housekeeping genes using the database maintained by Pasteur Institute, Paris, France (*<http://bigsdb.pasteur.fr/klebsiella/>*).

Genetic analysis: The relatedness of the predicted sequence types was investigated by eBURST V3 software employing the BURST algorithm[@ref18]. Splits Tree4 programme version 4.14.6 was used to determine the phylogenetic relatedness among the various clonal types based on the seven house-keeping genes that define the MLST[@ref19]. Using the concatenated sequences of seven housekeeping genes of MLST, phylogenetic tree was constructed using MEGA v.7 (*<https://www.megasoftware.net/>*) and meta-data were added using iTOL (*<https://itol.embl.de/login.cgi>*).

Results {#sec1-3}
=======

All the 65 isolates were XDR being resistant to aminoglycosides, cephalosporins and fluoroquinolones and susceptible only to tigecycline; 10 blood isolates were susceptible to minocycline and two isolates each from exudates were susceptible to chloramphenicol and trimethoprim-sulphamethoxazole, respectively. The colistin MIC for the isolates ranged from 4 to 256 μg/ml. The mean colistin MIC value was found to be 19±31.9 μg/ml.

Among the ESBL genes, 60 per cent (n=40) of the isolates co-produced *bla*~SHV~, *bla*~TEM~ and *bla*~CTX-M-15~. *bla*~OXA48-like~ was the predominant carbapenemase gene produced in 71 per cent (n=47) followed by co-production of *bla*~NDM~ and *bla*~OXA48-like~ in 11 per cent (n=7), *bla*~NDM~ in seven per cent (n=5) and *bla*~KPC~ three per cent (n=2) and four isolates did not produce any of the carbapenemases genes tested. [Fig. 1](#F1){ref-type="fig"} shows the distribution of β-lactamases among the various clinical specimens.

![Distribution of β-lactamases in colistin-resistant *Klebsiella pneumoniae* among various clinical specimens.](IJMR-149-199-g001){#F1}

Colistin MIC, mutations in *mgrB, phoP* and *phoQ* and associated clonal types among the study isolates are shown in the [Table](#T1){ref-type="table"}. The mutations in *mgrB* observed among clinical specimens were among diverse clonal types. Fig. [2A](#F2){ref-type="fig"}--[E](#F2){ref-type="fig"} shows the association of *mgrB* with insertion sequences. A total of 41 isolates did not have mutations in *mgrB* and in 11 isolates *mgrB* gene was absent. Mutations in *phoP* and *phoQ* were present among six and nine isolates, respectively. Screening for *mcr-1* and *mcr-3* genes by PCR was negative for all the isolates.

###### 

Mutations in *mgrB, phoP* and *phoQ* genes among the colistin-resistant *Klebsiella pneumoniae*

  Isolate ID   Source        Colistin MIC (µg/ml)   MLST     Carbapenemase   *mgrB*                                                                                                    *phoP*                             *phoQ*                                                                        Accession number
  ------------ ------------- ---------------------- -------- --------------- --------------------------------------------------------------------------------------------------------- ---------------------------------- ----------------------------------------------------------------------------- ---------------------------------
  Kp1          Blood         16                     ST86     Nil             Nil                                                                                                       Alanine 114 arginine (0.22)        Leucine 209 cysteine (0.00^\*^)                                               ^b^PAW96459.1 ^c^NRQZ01000030.1
  Kp2          Blood         32                     ST11     Nil             Elongated *mgrB* of 55 amino acids                                                                        Nil                                Nil                                                                           ^a^PBD34554.1
  Kp3          Blood         16                     ST14     OXA48-like      Nil                                                                                                       Nil                                Tryptophan 161 leucine (0.30)                                                 ^c^MH211110
  Kp4          Blood         32                     ST14     OXA48, NDM      No amplification                                                                                          Nil                                Tryptophan 161 leucine (0.30)                                                 ^c^MH211111
  Kp5          Blood         32                     ST14     OXA48-like      Truncated by IS1R of IS1 family                                                                           Nil                                Nil                                                                           ^a^MH590725
  Kp6          Blood         8                      ST231    OXA48-like      Premature stop codon at 21^st^ amino acid and change in the sequence of protein after 10^th^ amino acid   Nil                                Nil                                                                           ^a^MH807824
  Kp7          Blood         8                      ST15     KPC             Truncated by IS903B group of IS5 family                                                                   Nil                                Nil                                                                           ^a^MH590724
  Kp8          Blood         16                     ST231    OXA48-like      Truncated by IS*Kpn1*4 of IS1 family                                                                      Nil                                Nil                                                                           ^a^MH590726
  Kp9          CSF           16                     ST14     OXA48-like      Truncated by IS*Kpn*26 of IS5 family                                                                      Nil                                Changes from 218 to 239 and 436 to 448 amino acids                            ^a^MH590727 ^c^MH807825
  Kp10         Exudate       8                      ST23     NDM             Nil                                                                                                       Nil                                Glycine 117 aspartic acid (1.00)                                              ^c^MH211112
  Kp11         Exudate       4                      ST2096   OXA48-like      Nil                                                                                                       Nil                                Valine 370 glutamic acid (0.03^\*^)                                           ^c^MH211113
  Kp12         Exudate       32                     ST14     OXA48, NDM      Cysteine to glycine at 28^th^ amino acid (0.00^\*^)                                                       Threonine 151 Alanine (0.00^\*^)   Nil                                                                           ^a^MH337365 ^b^MH211116
  Kp13         Exudate       16                     ST147    OXA48, NDM      Nil                                                                                                       Glutamic acid 22 lysine (0.49)     Nil                                                                           ^b^MH211117
  Kp14         Exudate       32                     ST231    OXA48-like      Premature stop codon at 21^st^ amino acid and change in the sequence of protein after 10^th^ amino acid   Nil                                Nil                                                                           ^a^MH807823
  Kp15         Respiratory   32                     ST14     NDM             Cysteine to glycine at 28^th^ amino acid (0.00^\*^)                                                       Nil                                Leucine 172 glutamine (0.01^\*^); Tryptophan 182 serine (0.04^\*^)            ^a^MH337366 ^c^MH211114
  Kp16         Respiratory   8                      ST231    OXA48-like      Nil                                                                                                       Nil                                Valine444^\^^, phenylalanine 445 glycine (0.00^\*^)                           ^c^MH211115
  Kp17         Respiratory   8                      ST147    OXA48-like      Methionine to arginine first amino acid (0.00^\*^)                                                        Nil                                Nil                                                                           ^a^MH590728
  Kp18         Respiratory   16                     ST231    OXA48-like      Premature stop codon at 21^st^ amino acid and change in the sequence of protein after 10^th^ amino acid   Nil                                Nil                                                                           ^a^MH337364
  Kp19         Respiratory   8                      ST2957   KPC-9           No mutation; associated with IS102 of IS5 family                                                          Nil                                Proline 424 leucine (0.37) V446W (0.00^\*^), change from 448^th^ amino acid   ^a^PAT25546.1 ^c^CJ307_16160

^a^*mgrB* accession number; ^b^*phoP* accession number; ^c^*phoQ* accession number. Numbers in parenthesis indicate the SIFT score; values with ^\*^\<0.05 show that the mutation affects the protein function. ^\#^Position of insertion in *mgrB* gene. ^\^^Indicates Valine deletion at 444^th^ position in *phoQ*. MLST, multilocus sequence typing; SIFT, sorting intolerant from tolerant; MIC, minimum inhibitory concentration; IS, insertion sequence

![(A) Insertion sequence (IS) associated with *mgrB* in Kp2; (B) IS1R inserts at 132^nd^ position in *mgrB* in Kp7; (C) Insertion of IS*Kpn26* between 66^th^ and 67^th^ bases of *mgrB* in Kp14 with repeats of 9 bases; (D) Insertion of IS903B between 34^th^ and 35^th^ bases of *mgrB* in Kp19 with repeats of 29 bases; (E) Insertion of IS*Kpn14* at 93^rd^ position of *mgrB* in Kp20.](IJMR-149-199-g002){#F2}

SIFT score was calculated to predict the effect of amino acid substitutions identified in this study isolates. In *mgrB*, both the substitutions Met1Ala and Cys28Gly were found deleterious. In *phoP*, among the three substitutions observed, Ala114Arg, Glu22Lys showed a score of 0.22 and 0.49, while Thr151Ala scored zero and found significant and deleterious. Similarly, in *phoQ*, mutations such as Leu205Gln, Leu209Cys, Trp215Ser, Val403Glu, Val446Trp and Phe478Gly were predicted to affect the function of the protein. Non-significant mutations of Trp194Leu (*phoQ*) in Kp7, Kp8 and Glu22Lys (*phoP*) in Kp13 were also noted.

Totally, 15 different sequence types were obtained among the 65 isolates and these included ST231 (n=23), ST14 (n=13), ST2096 (n=9), ST 147 (n=5), ST78 (n=3), ST15 (n=2), ST16 (n=2) and one isolate each of ST11, ST17, ST23, ST38, ST43, ST86, ST395 and ST2957. [Fig. 3](#F3){ref-type="fig"} shows the eBURST analysis for the clonal types among the study isolates. ST17 and ST16 belonged to the same clonal complex; while ST14, ST15, ST78 and ST2096 form another clonal complex, CC14. Other sequence types such as ST11, ST23, ST43, ST147 and ST231 were found as singletons.

![eBURST of colistin-resistant *Klebsiella pneumoniae*. The clonal types identified in the present study are highlighted. ST17 and ST16 belonged to the same clonal complex; ST14, ST15, ST78 and ST2096 formed a clonal complex. Other sequence types such as ST11, ST23, ST38, ST43, ST86, ST147, ST231 and ST395 were found as singletons.](IJMR-149-199-g003){#F3}

Among the study isolates, KP harbouring carbapenemases were of diverse sequence types. Overall, ST14 was the most predominant. Among the STs, OXA48-like producers were distributed among diverse clonal types such as ST14, ST16, ST17, ST38, ST43, ST231, ST395 and ST2096. Co-producers of *bla*~NDM~ with *bla*~OXA48~ (n=6) belonged to ST14, ST78 and ST147. Isolates producing *bla*~NDM~ (n=6) alone belonged to ST14, ST15, ST23 and ST78. Two of the study isolates were *bla*~KPC~ producers, each belonging to ST15 and ST2957.

[Fig. 4](#F4){ref-type="fig"} shows the Splits Tree diagram for the sequence types. All the clonal types were closely related except ST2957 which was an outlier. The outlier was identified as *K. quasipneumoniae* belonging to phylogenetic group II of KP. [Fig. 5](#F5){ref-type="fig"} shows the maximum likelihood tree constructed based on the concatenated sequences of seven housekeeping genes used for MLST. As shown, isolates of ST231 were OXA48-like carbapenemase producers and was the predominant clone. The isolates of CC14 were more diverse in carbapenemases producing New Delhi metallo-β-lactamase (NDM) and/ or OXA48-like and one isolate with KPC. [Fig. 5](#F5){ref-type="fig"} also shows the clones present among different specimen sources. The isolates with chromosomal mutations contributing to colistin resistance ([Table](#T1){ref-type="table"}) are also indicated and the distribution of carbapenemases among these isolates is evident from [Fig. 5](#F5){ref-type="fig"}.

![Splits Tree for the clonal types identified among colistin-resistant *Klebsiella pneumoniae*. Fifteen clonal types identified in the study were closely related forming a cluster while ST2957 was distinct. The tree was constructed based on seven housekeeping genes.](IJMR-149-199-g004){#F4}

![Maximum likelihood tree for colistin-resistant *Klebsiella pneumoniae* using concatenated sequences of seven multilocus sequence typing genes.](IJMR-149-199-g005){#F5}

Discussion {#sec1-4}
==========

In this study molecular resistance mechanisms were assessed and clonal relatedness of colistin-resistant KP was investigated. SHV, TEM and CTX-M-15 were the prevalent β-lactamases similar to earlier study[@ref20]. Among the study isolates, OXA48-like was the commonest carbapenemase produced. In this study, colistin resistance was contributed by mutations in *mgrB, phoP* and *phoQ* genes in the isolates. Our earlier study identified truncated *mgrB* of 27 amino acids due to a premature stop codon and also deletion of A at 10^th^ nucleotide[@ref2]. However, in the present study, these two mutations were absent, but various other mutations were seen. All the *mgrB* negatives could be due to partial or complete deletion of *mgrB* as reported previously[@ref21]. The disruption of *mgrB* due to insertion elements such as IS1R, IS903, IS*Kpn14* and IS*Kpn26* similar to the present study have been reported earlier[@ref21][@ref22][@ref23]. The *mgrB* mutations were not associated with specific carbapenemases or specific clones. There was no association between colistin MIC, *mgrB* mutations and specific clones. Substitutions in the *phoP* and *phoQ* genes implicated in colistin resistance have been reported[@ref23]. However, certain mutations observed in the present study were novel. The significance of these novel mutations were predicted using SIFT scores. These scores revealed that the novel mutations were likely to affect protein function. However, detailed functional properties of mutations need to be determined by cloning studies to substantiate its significance.

Clonal relatedness with antimicrobial resistance profile in colistin-resistant KP was determined. New Delhi metallo-β-lactamase (NDM) producing KP are known to be associated with ST11, ST14, ST147 and ST231 in India and globally[@ref2][@ref24][@ref25] while the two KPC KP belong to ST15 and ST2957. International KPC clones such as ST258 and ST512 were absent among the study collection.

The colistin-resistant isolates in the present study were diverse and 15 clones were observed among the isolates. ST14, ST231 and ST2096 were predominant. The truncation of *mgrB* due to IS5-like elements[@ref21][@ref22] and IS*Kpn14*[@ref23][@ref26] has been reported among ST258, ST512 and ST101. IS*Kpn*26 has been reported among OXA48-like producer belonging to ST307[@ref26]. In the present study, these were seen among isolates belonging to ST14, ST15 and ST231. Substitutions previously reported in *phoP*[@ref23][@ref27] and *phoQ*[@ref23][@ref27] were among isolates of ST147 and ST258.

Isolate belonging to ST23 produced NDM; also carried *rmpA* and *rmpA2* genes indicating hypervirulent KP. Earlier, carbapenem-resistant hypervirulent KP belonging to ST14 and ST231[@ref28] has been reported. These two clones are classically associated with carbapenem-resistant isolates in India and other countries[@ref2][@ref20]. A novel ST2957 was observed in the present study. Earlier in India, Shankar *et al*[@ref29] have reported pan-susceptible hypervirulent *K. quasipneumoniae* of novel clone ST2320.

The association between the MLST sequence types and the molecular resistance mechanisms was not observed. This could be due to the limited relatedness information provided by MLST. Whole genome SNP-based phylogeny may provide further insights into the strain-specific lineage within a particular sequence type/clonal complex[@ref30]. A previous study revealed that 97 per cent of KPC KP isolates sequenced, regardless of country of isolation, belong to a well-supported clade, corresponding to the complex CC258 based on the whole genome phylogeny[@ref30]. MLST can be used to understand the epidemiology at a large scale while whole genome SNP phylogeny would be discriminatory in local outbreak situations.

The mechanism of colistin resistance in isolates which lacked mutations in *mgrB, phoP* and *phoQ* were not determined. This was a limitation of the study since in 70 per cent of study isolates the mechanism of colistin resistance was unidentified.

In conclusion, this study revealed the changing trend of carbapenem resistance mechanism predominantly to OXA48-like from NDM. There is alarming increase in colistin resistance with novel mutations in chromosomal genes such as *mgrB, phoP* and *phoQ*. There was no plasmid-mediated colistin resistance. Diverse clones of colistin-resistant isolates were observed with CG14 being predominant. No known international clones such as ST258 and ST512 were observed. It is important to monitor colistin resistance by using appropriate testing method and also limit colistin usage.
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